Share on: 
Website: Wugen

Wugen is developing off-the-shelf cellular therapies for cancer. Their NK cell therapy products originate from healthy donors and are further manipulated in order to enhance their function to eliminate cancer cells. Our NK cell and CAR-T immuno-oncology therapies address the needs of patients with solid tumors, acute myeloid leukemia (AML) and T-cell malignancies.

Career Page(s): 
St. Louis MO
United States
San Diego CA
United States